Cystatin forms a tetramer through structural rearrangement of domain-swapped dimers prior to amyloidogenesis

被引:79
作者
Sanders, A [1 ]
Craven, CJ [1 ]
Higgins, LD [1 ]
Giannini, S [1 ]
Conroy, MJ [1 ]
Hounslow, AM [1 ]
Waltho, JP [1 ]
Staniforth, RA [1 ]
机构
[1] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England
基金
英国工程与自然科学研究理事会; 英国惠康基金;
关键词
cystatin; amyloid intermediate; CAA; domain-swapping; dimer;
D O I
10.1016/j.jmb.2003.12.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cystatins were the first amyloidogenic proteins to be shown to oligomerize through a 3D domain swapping mechanism. Here we show that, under conditions leading to the formation of amyloid deposits, the domain-swapped dimer of chicken cystatin further oligomerizes to a tetramer, prior to fibrillization. The tetramer has a very similar circular dichroism and fluorescence signature to the folded monomer and dimer structures, but exhibits some loss of dispersion in the H-1-NMR spectrum. 8-Anilino-1-naphthalene sulfonate fluorescence enhancement indicates an increase in the degree of disorder. While the dimerization reaction is bimolecular and most likely limited by the availability of a predominantly unfolded form of the monomer, the tetramerization reaction is first-order. The tetramer is formed slowly (t(1/2) = six days at 85 degreesC), dimeric cystatin is the precursor to tetramer formation, and thus the rate is limited by structural rearrangement within the dimer. Some higher-order oligomerization events parallel tetramer formation while others follow from the tetrameric form. Thus, the tetramer is a transient intermediate within the pathway of large-scale oligomerization. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:165 / 178
页数:14
相关论文
共 78 条
[1]   INCREASED BODY-TEMPERATURE ACCELERATES AGGREGATION OF THE LEU-68 -] GLN MUTANT CYSTATIN-C, THE AMYLOID-FORMING PROTEIN IN HEREDITARY CYSTATIN-C AMYLOID ANGIOPATHY [J].
ABRAHAMSON, M ;
GRUBB, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (04) :1416-1420
[2]  
Abrahamson M, 1996, SCAND J CLIN LAB INV, V56, P47
[3]   CYSTATIN, A PROTEIN INHIBITOR OF CYSTEINE PROTEINASES - IMPROVED PURIFICATION FROM EGG-WHITE, CHARACTERIZATION, AND DETECTION IN CHICKEN SERUM [J].
ANASTASI, A ;
BROWN, MA ;
KEMBHAVI, AA ;
NICKLIN, MJH ;
SAYERS, CA ;
SUNTER, DC ;
BARRETT, AJ .
BIOCHEMICAL JOURNAL, 1983, 211 (01) :129-138
[4]   Supramolecular structure in full-length Alzheimer's β-amyloid fibrils:: Evidence for a parallel β-sheet organization from solid-state nuclear magnetic resonance [J].
Balbach, JJ ;
Petkova, AT ;
Oyler, NA ;
Antzutkin, ON ;
Gordon, DJ ;
Meredith, SC ;
Tycko, R .
BIOPHYSICAL JOURNAL, 2002, 83 (02) :1205-1216
[5]   THE CYSTATINS - A NEW CLASS OF PEPTIDASE INHIBITORS [J].
BARRETT, AJ .
TRENDS IN BIOCHEMICAL SCIENCES, 1987, 12 (05) :193-196
[6]   THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN-C) AMONGST THE CYSTEINE PROTEINASE-INHIBITORS [J].
BARRETT, AJ ;
DAVIES, ME ;
GRUBB, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (02) :631-636
[7]   Pathway complexity of prion protein assembly into amyloid [J].
Baskakov, IV ;
Legname, G ;
Baldwin, MA ;
Prusiner, SB ;
Cohen, FE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) :21140-21148
[8]   Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix [J].
Blake, C ;
Serpell, L .
STRUCTURE, 1996, 4 (08) :989-998
[9]   Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis [J].
Booth, DR ;
Sunde, M ;
Bellotti, V ;
Robinson, CV ;
Hutchinson, WL ;
Fraser, PE ;
Hawkins, PN ;
Dobson, CM ;
Radford, SE ;
Blake, CCF ;
Pepys, MB .
NATURE, 1997, 385 (6619) :787-793
[10]   Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D) .1. A review of clinical, radiologic and genetic aspects [J].
Bornebroek, M ;
Haan, J ;
MaatSchieman, MLC ;
VanDuinen, SG ;
Roos, RAC .
BRAIN PATHOLOGY, 1996, 6 (02) :111-114